NCT04820413

Brief Summary

Patients with chronic pouchitis is disabled by bloody diarrhoea and abdominal pain often followed by fever. Pouchitis is an inflammation in a pouch, a reservoir formed by the small intestine in the management of the chronic inflammatory bowel disease, ulcerative colitis. The standard treatment for pouchitis is intensive broad-spectrum antibiotics for a longer period. However, the treatment often fails after repeated treatments. Studies show that patients with pouchitis have an altered composition of the gut microbiota compared to healthy individuals and patients with a pouch without inflammation. As shown by several studies, faecal microbiota transplantation (FMT) with administration of faeces from healthy donors can alter the microbiota. Treatment with faecal microbiota transplantation to chronic pouchitis has been investigated in several clinical trials with mixed results. It is however still uncertain if faecal microbiota transplantation using stool from healthy individuals with a colon is optimal, or if stool from patient with a normally functioning pouch should be used. The study primary aims to investigate if transplantation of faeces from patient with a normal pouch function can induce clinical remission in patients with chronic pouchitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

March 25, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 29, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2022

Completed
Last Updated

July 13, 2022

Status Verified

July 1, 2022

Enrollment Period

1 year

First QC Date

March 25, 2021

Last Update Submit

July 12, 2022

Conditions

Keywords

FMTMicrobiota

Outcome Measures

Primary Outcomes (1)

  • Number of patients achieving clinical remission assessed by PDAI

    Clinical remission is defined as PDAI\<7

    4 weeks

Secondary Outcomes (2)

  • Number of patients achieving clinical response assessed by PDAI

    4 weeks

  • Engraftment of the donor microbiota in the patients

    4 weeks

Study Arms (1)

FMT

EXPERIMENTAL
Other: Faecal microbiota transplantation

Interventions

FMT by daily enema with donor faeces

FMT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ≥ 18 years of age with a J-pouch
  • PDAI ≥ 7
  • Established diagnosis of chronic pouchitis (≥3 times of pouchitis within the last year, symptoms more than 4 weeks despite antibiotic treatment)
  • Antibiotic treatment for pouchitis (ciprofloxacin and/or metronidazole) within the 3 months

You may not qualify if:

  • Immunosuppression
  • Pregnancy or breastfeeding
  • Any severe or newly diagnosed concomitant cardiovascular, hepatic, intestinal, renal, endocrine, pulmonary, dental disease with inflammation or psychiatric disorder, which, in the opinion of the investigator, might have an influence on the patient's compliance or the interpretation of the results
  • Probiotic intake within the last 2 weeks prior to study intervention
  • Participation in another clinical trial within the previous 30 days before baseline
  • Serious food allergies with earlier anaphylactic reactions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Gastrointestinal Surgery, Aalborg University Hospital

Aalborg, 9000, Denmark

Location

MeSH Terms

Conditions

PouchitisInflammatory Bowel DiseasesColitis, Ulcerative

Interventions

Fecal Microbiota Transplantation

Condition Hierarchy (Ancestors)

IleitisEnteritisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesIleal DiseasesColitisColonic Diseases

Intervention Hierarchy (Ancestors)

Biological TherapyTherapeutics

Study Officials

  • Ole Thorlacius-Ussing, Professor

    Aalborg University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor of surgery, Consultant surgeon, DMSc

Study Record Dates

First Submitted

March 25, 2021

First Posted

March 29, 2021

Study Start

March 1, 2021

Primary Completion

March 15, 2022

Study Completion

March 15, 2022

Last Updated

July 13, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations